Fiche publication


Date publication

mai 2023

Journal

American journal of clinical dermatology

Auteurs

Membres identifiés du Cancéropôle Est :
Dr AMARAL Teresa Maria


Tous les auteurs :
Chatziioannou E, Leiter U, Thomas I, Keim U, Seeber O, Meiwes A, Boessenecker I, Gonzalez SS, Torres FM, Niessner H, Sinnberg T, Forschner A, Flatz L, Amaral T

Résumé

Immune checkpoint inhibition (ICI) has changed the melanoma treatment spectrum. Few studies have examined the characteristics and long-term outcomes of patients achieving complete response (CR) under ICI.

Mots clés

Humans, Aged, Melanoma, Prognosis, Remission Induction, Progression-Free Survival, Immunotherapy, Retrospective Studies

Référence

Am J Clin Dermatol. 2023 05;24(3):453-467